Guardant Health Inc. Common Stock (GH)

About GH

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect can…

Sector

Health Care

Industry

Medical Specialities

Employees

2,490

Website

guardanthealth.com/

Fundamentals

1-day range

$160.23$169.6

Market cap

$21.31B

P/E (trailing)

—

P/E (forward)

-365.10

EPS (trailing)

$-3.50

Dividend yield

—

Beta

1.64

Avg. volume

2.58M

Forecasts

24 analyst ratings

Guardant Health Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• GH

  Guardant Health Inc. Common Stock

  $161.76

  ▼ 4.01%
  Market cap $21.31BP/E —
  $53.4$176.58
• ILMN

  Illumina Inc. Common Stock

  $215.65

  ▼ 5.29%
  Market cap $29.98BP/E 34.73
  $88$231.81
• CNC

  Centene Corporation Common Stock

  $64.77

  ▼ 0.86%
  Market cap $31.50BP/E —
  $28.24$69.36
• MOH

  Molina Healthcare Inc Common Stock

  $199.88

  ▲ 0.57%
  Market cap $10.17BP/E 1249.59
  $121.06$244.89
• OSCR

  Oscar Health Inc. Class A Common Stock

  $30.47

  ▲ 1.38%
  Market cap $9.27BP/E 16.85
  $10.69$33.55
• BLLN

  BillionToOne Inc. Class A Common Stock

  $93.27

  ▼ 1.98%
  Market cap $6.32BP/E 117.67
  $61.96$150.44
• CAI

  Caris Life Sciences Inc. Common Stock

  $25.64

  ▼ 2.81%
  Market cap $4.61BP/E 59.62
  $14.19$39.18

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Guardant Health Announces Appeal Of Delaware District Court Final Judgment In TwinStrand Patent Suit, With Execution And Royalty Collection Stayed Pending Appeal
  benzinga · 8/24/2026
• Guardant Health Hit With Ongoing Royalties Over Duplex Sequencing Tech
  Benzinga · 8/24/2026
• Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine Advance
  SeekingAlpha · 8/20/2026
• Guardant Health, Inc. (GH) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript
  SeekingAlpha · 8/12/2026
• Guardant Health: Screening And MRD Are Just Getting Started
  SeekingAlpha · 8/11/2026
• Caris Life Sciences: Guidance Raised, Valuation Still Attractive
  SeekingAlpha · 8/6/2026
• Alger Small Cap Focus Fund Q2 2026 Portfolio Review
  SeekingAlpha · 8/6/2026
• Piper Sandler Maintains Overweight on Guardant Health, Raises Price Target to $193
  Benzinga · 8/4/2026
• Stephens & Co. Maintains Overweight on Guardant Health, Raises Price Target to $195
  Benzinga · 8/4/2026

• Helmy Eltoukhy · August 26, 2026 · Gift

  30.0K
• Helmy Eltoukhy · August 26, 2026 · J

  25.0K
• AmirAli Talasaz · August 21, 2026 · Sale

  7.6K @ $170.29
• AmirAli Talasaz · August 21, 2026 · Sale

  20.9K @ $169.16
• AmirAli Talasaz · August 21, 2026 · Sale

  9.0K @ $168.2
• Roberto Mignone · August 21, 2026 · Option Exercise

  264
• Terilyn J. Monroe · August 12, 2026 · Option Exercise

  14.0K @ $28.61
• Terilyn J. Monroe · August 12, 2026 · Option Exercise

  32.3K @ $20.14
• Terilyn J. Monroe · August 12, 2026 · Sale

  400 @ $167.92
• Terilyn J. Monroe · August 12, 2026 · Sale

  13.2K @ $166.11
• Terilyn J. Monroe · August 12, 2026 · Sale

  19.0K @ $165.16
• Terilyn J. Monroe · August 12, 2026 · Sale

  9.9K @ $164.27
• Terilyn J. Monroe · August 12, 2026 · Sale

  3.7K @ $163.41
• Helmy Eltoukhy · August 11, 2026 · Gift

  35.0K
• AmirAli Talasaz · August 10, 2026 · Gift

  75.0K

Institutional Ownership

March 31, 2026

Total shares held

131.88M

Total value held

$11.05B

Institutional holders

478